{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:10:41Z","timestamp":1788307841581,"version":"build-2803163510"},"reference-count":63,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Guillain\u2013Barr\u00e9 syndrome (GBS) is an inflammatory disorder and an acute immune-mediated demyelinating neuropathy that causes reduced signal transmissions, progressive muscle weakness, and paralysis. The etiology of the syndrome still remains controversial and uncertain. GBS can be initiated and triggered by respiratory tract infections such as influenza, and intestinal infections such as <jats:italic>Campylobacter jejuni<\/jats:italic>. In addition, there is considerable evidence suggesting links between influenza vaccination and GBS. As reported previously, the incidence of GBS in individuals receiving swine flu vaccine was about one to two cases per million. Despite the influenza vaccine efficacy, its association with an immune-mediated demyelinating process can be challenging as millions of people get vaccinated every year. In this review we will discuss the association between influenza infection and vaccination with GBS by focusing on the possible immunopathological mechanisms.<\/jats:p>","DOI":"10.2478\/jtim-2019-0028","type":"journal-article","created":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T09:31:14Z","timestamp":1579339874000},"page":"137-142","source":"Crossref","is-referenced-by-count":42,"title":["Influenza vaccination and Guillain\u2013Barr\u00e9 syndrome: Reality or fear"],"prefix":"10.2478","volume":"7","author":[{"given":"Arefeh","family":"Babazadeh","sequence":"first","affiliation":[{"name":"Infectious Diseases and Tropical Medicine Research Center , Health Research Institute , Babol University of Medical Sciences , Babol , I.R. Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Mohseni Afshar","sequence":"additional","affiliation":[{"name":"Clinical Research Development Center , Imam Reza Hospital , Kermanshah University of Medical Sciences , Kermanshah , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Javanian","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Tropical Medicine Research Center , Health Research Institute , Babol University of Medical Sciences , Babol , I.R. Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mousa","family":"Mohammadnia-Afrouzi","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Tropical Medicine Research Center , Health Research Institute , Babol University of Medical Sciences , Babol , I.R. Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Karkhah","sequence":"additional","affiliation":[{"name":"Student Research Committee, School of Medicine , Babol University of Medical Sciences , Babol , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jila","family":"Masrour-Roudsari","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Tropical Medicine Research Center , Health Research Institute , Babol University of Medical Sciences , Babol , I.R. Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Sabbagh","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Tropical Medicine Research Center , Health Research Institute , Babol University of Medical Sciences , Babol , I.R. Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerendra","family":"Koppolu","sequence":"additional","affiliation":[{"name":"Scientist Biopharmaceutical Development Medimmune Gaithersburg , MD 20878 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veneela KrishnaRekha","family":"Vasigala","sequence":"additional","affiliation":[{"name":"Rangaraya Medical College , NTR University of Health Sciences , Kakinada , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheil","family":"Ebrahimpour","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Tropical Medicine Research Center , Health Research Institute , Babol University of Medical Sciences , Babol , I.R. Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2019,12,31]]},"reference":[{"key":"2023042508114206751_j_jtim-2019-0028_ref_001_w2aab3b7b4b1b6b1ab1c11b1Aa","doi-asserted-by":"crossref","unstructured":"Goodfellow JA, Willison HJ. Guillain\u2013Barr\u00e9 syndrome: a century of progress. Nat Rev Neurol 2016;12:723\u201331.","DOI":"10.1038\/nrneurol.2016.172"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_002_w2aab3b7b4b1b6b1ab1c11b2Aa","doi-asserted-by":"crossref","unstructured":"Jasti AK, Selmi C, Sarmiento-Monroy JC, Vega DA, Anaya J-M, Gershwin ME. Guillain-Barr\u00e9 syndrome: causes, immunopathogenic mechanisms and treatment. Expert Rev Clin Immunol 2016;12:1175\u201389.","DOI":"10.1080\/1744666X.2016.1193006"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_003_w2aab3b7b4b1b6b1ab1c11b3Aa","unstructured":"Tandel H, Vanza J, Pandya N, Jani P. Guillain-barr\u00e9 syndrome (GBS): A Review2016; 366\u201371."},{"key":"2023042508114206751_j_jtim-2019-0028_ref_004_w2aab3b7b4b1b6b1ab1c11b4Aa","doi-asserted-by":"crossref","unstructured":"Galeotti F, Massari M, D\u2019Alessandro R, Beghi E, Chi\u00f2 A, Logroscino G, et al. Risk of Guillain-Barr\u00e9 syndrome after 2010\u20132011 influenza vaccination. Eur J Epidemiol 2013;28:433\u201344.","DOI":"10.1007\/s10654-013-9797-8"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_005_w2aab3b7b4b1b6b1ab1c11b5Aa","doi-asserted-by":"crossref","unstructured":"Wang YZ, Lv H, Shi QG, Fan XT, Li L, Yi Wong AH, et al. Action mechanism of corticosteroids to aggravate Guillain-Barr\u00e9 syndrome. Sci Rep 2015;5:13931.","DOI":"10.1038\/srep13931"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_006_w2aab3b7b4b1b6b1ab1c11b6Aa","doi-asserted-by":"crossref","unstructured":"Dimachkie MM, Barohn RJ. Guillain-Barr\u00e9 Syndrome and Variants. Neurol Clin 2013;31:491\u2013510.","DOI":"10.1016\/j.ncl.2013.01.005"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_007_w2aab3b7b4b1b6b1ab1c11b7Aa","doi-asserted-by":"crossref","unstructured":"Karkhah A, Nouri HR, Javanian M, Koppolu V, Masrour-Roudsari J, Kazemi S, et al. Zika virus: epidemiology, clinical aspects, diagnosis, and control of infection. Eur J Clin Microbiol Infect Dis 2018;37:2035\u201343.","DOI":"10.1007\/s10096-018-3354-z"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_008_w2aab3b7b4b1b6b1ab1c11b8Aa","doi-asserted-by":"crossref","unstructured":"Green C, Baker T, Subramaniam A. Predictors of respiratory failure in patients with Guillain\u2013Barr\u00e9 syndrome: a systematic review and meta-analysis. Med J Aust 2018;208:181\u20138.","DOI":"10.5694\/mja17.00552"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_009_w2aab3b7b4b1b6b1ab1c11b9Aa","doi-asserted-by":"crossref","unstructured":"Kalita J, Ranjan A, Misra UK. Outcome of Guillain-Barre syndrome patients with respiratory paralysis. QJM 2016;109:319\u201323.","DOI":"10.1093\/qjmed\/hcv190"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_010_w2aab3b7b4b1b6b1ab1c11c10Aa","doi-asserted-by":"crossref","unstructured":"Netto AB, Taly AB, Kulkarni GB, Rao UGS, Rao S. Mortality in mechanically ventilated patients of Guillain Barr\u00e9 Syndrome. Ann Indian Acad Neurol 2011;14:262\u20136.","DOI":"10.4103\/0972-2327.91942"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_011_w2aab3b7b4b1b6b1ab1c11c11Aa","doi-asserted-by":"crossref","unstructured":"Buzzigoli SB, Genovesi M, Lambelet P, Logi C, Raffaelli S, Cattano D. Plasmapheresis treatment in Guillain-Barre syndrome: potential benefit over intravenous immunoglobulin. Anaesth Intensive Care 2010;38:387\u20139.","DOI":"10.1177\/0310057X1003800225"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_012_w2aab3b7b4b1b6b1ab1c11c12Aa","doi-asserted-by":"crossref","unstructured":"Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barre syndrome. Cochrane Database Syst Rev 2014:Cd002063.","DOI":"10.1002\/14651858.CD002063.pub6"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_013_w2aab3b7b4b1b6b1ab1c11c13Aa","doi-asserted-by":"crossref","unstructured":"Rocha MS, Brucki SM, Carvalho AA, Lima UW. Epidemiologic features of Guillain-Barre syndrome in Sao Paulo, Brazil. Arq Neuropsiquiatr 2004;62:33\u20137.","DOI":"10.1590\/S0004-282X2004000100006"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_014_w2aab3b7b4b1b6b1ab1c11c14Aa","doi-asserted-by":"crossref","unstructured":"Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population Incidence of Guillain-Barr\u00e9 Syndrome: A Systematic Review and Meta-Analysis. Neuroepidemiology 2011;36:123\u201333.","DOI":"10.1159\/000324710"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_015_w2aab3b7b4b1b6b1ab1c11c15Aa","doi-asserted-by":"crossref","unstructured":"Harms M. Inpatient Management of Guillain-Barr\u00e9 Syndrome. Neurohospitalist 2011;1:78\u201384.","DOI":"10.1177\/1941875210396379"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_016_w2aab3b7b4b1b6b1ab1c11c16Aa","doi-asserted-by":"crossref","unstructured":"Greene SK, Rett MD, Vellozzi C, Li L, Kulldorff M, Marcy SM, et al. Guillain-Barre Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009\u20132011. PLoS One 2013;8:e67185.","DOI":"10.1371\/journal.pone.0067185"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_017_w2aab3b7b4b1b6b1ab1c11c17Aa","doi-asserted-by":"crossref","unstructured":"Hughes R. Campylobacter jejuni in Guillain-Barre syndrome. Lancet Neurol 2004;3:644.","DOI":"10.1016\/S1474-4422(04)00902-0"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_018_w2aab3b7b4b1b6b1ab1c11c18Aa","doi-asserted-by":"crossref","unstructured":"Kim SY, Choe K-W, Park S, Yoon D, Ock C-Y, Hong SW, et al. Mild form of Guillain-Barr\u00e9 syndrome in a patient with primary Epstein-Barr virus infection. Korean J Intern Med 2016;31:1191\u20133.","DOI":"10.3904\/kjim.2015.033"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_019_w2aab3b7b4b1b6b1ab1c11c19Aa","doi-asserted-by":"crossref","unstructured":"Merzkani M, Israel E, Sachdeva M. Primary Cytomegalovirus Infection Causing Guillain-Barr\u00e9 Syndrome in a Living Renal Allograft Recipient. Case Rep Transplant 2017;2017:7264793.","DOI":"10.1155\/2017\/7264793"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_020_w2aab3b7b4b1b6b1ab1c11c20Aa","doi-asserted-by":"crossref","unstructured":"Ntziora F, Euthimiou A, Tektonidou M, Andreopoulos A, Konstantopoulos K. Guillain-Barre syndrome presenting with sensory disturbance following a herpes virus infection: a case report. J Med Case Rep 2011;5:563.","DOI":"10.1186\/1752-1947-5-563"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_021_w2aab3b7b4b1b6b1ab1c11c21Aa","doi-asserted-by":"crossref","unstructured":"Wachira VK, Peixoto HM, de Oliveira MRF. Systematic review of factors associated with the development of Guillain-Barre syndrome 2007\u20132017: what has changed? Trop Med Int Health 2019; 24:132\u201342.","DOI":"10.1111\/tmi.13181"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_022_w2aab3b7b4b1b6b1ab1c11c22Aa","unstructured":"Javanian M, Masrour-Roudsari J, Ebrahimpour S. Clinical diagnosis challenges in Zika virus infection. Caspian J Intern Med 2018;9:416\u20137."},{"key":"2023042508114206751_j_jtim-2019-0028_ref_023_w2aab3b7b4b1b6b1ab1c11c23Aa","doi-asserted-by":"crossref","unstructured":"Vellozzi C, Iqbal S, Broder K. Guillain-Barr\u00e9 Syndrome, Influenza, and Influenza Vaccination: The Epidemiologic Evidence. Clin Infect Dis 2014;58:1149\u201355.","DOI":"10.1093\/cid\/ciu005"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_024_w2aab3b7b4b1b6b1ab1c11c24Aa","doi-asserted-by":"crossref","unstructured":"Yamamoto N, Suzuki S, Suzuki Y, Shirai A, Nakazawa M, Suzuki M, et al. Immune Response Induced by Airway Sensitization after Influenza A Virus Infection Depends on Timing of Antigen Exposure in Mice. J Virol 2001;75:499\u2013505.","DOI":"10.1128\/JVI.75.1.499-505.2001"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_025_w2aab3b7b4b1b6b1ab1c11c25Aa","doi-asserted-by":"crossref","unstructured":"Martini R, Willison H. Neuroinflammation in the peripheral nerve: Cause, modulator, or bystander in peripheral neuropathies? Glia 2016;64:475\u201386.","DOI":"10.1002\/glia.22899"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_026_w2aab3b7b4b1b6b1ab1c11c26Aa","doi-asserted-by":"crossref","unstructured":"Ydens E, Cauwels A, Asselbergh B, Goethals S, Peeraer L, Lornet G, et al. Acute injury in the peripheral nervous system triggers an alternative macrophage response. J Neuroinflammation 2012;9:176.","DOI":"10.1186\/1742-2094-9-176"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_027_w2aab3b7b4b1b6b1ab1c11c27Aa","doi-asserted-by":"crossref","unstructured":"Yuki N. Guillain-Barr\u00e9 syndrome and anti-ganglioside antibodies: a clinician-scientist\u2019s journey. Proc Jpn Acad Ser B Phys Biol Sci 2012;88:299\u2013326.","DOI":"10.2183\/pjab.88.299"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_028_w2aab3b7b4b1b6b1ab1c11c28Aa","doi-asserted-by":"crossref","unstructured":"Wanschitz J, Maier H, Lassmann H, Budka H, Berger T. Distinct time pattern of complement activation and cytotoxic T cell response in Guillain\u2013Barr\u00e9 syndrome. Brain 2003;126:2034\u201342.","DOI":"10.1093\/brain\/awg207"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_029_w2aab3b7b4b1b6b1ab1c11c29Aa","doi-asserted-by":"crossref","unstructured":"Javanian M, Babazadeh A, Ebrahimpour S, Shokri M, Bayani M. Clinical and laboratory findings of patients with the possible diagnosis of influenza hospitalized in affiliated hospitals of Babol University of Medical Sciences, 2015\u20132016. Current Issues in Pharmacy and Medical Sciences 2018;31:113\u201316.","DOI":"10.1515\/cipms-2018-0022"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_030_w2aab3b7b4b1b6b1ab1c11c30Aa","doi-asserted-by":"crossref","unstructured":"ZABLOCKIEN\u0116 B, KA\u010cERGIUS T, AMBROZAITIS A, \u017dURAUSKAS E, BRATCHIKOV M, JURGAUSKIEN\u0116 L, et al. Zanamivir Diminishes Lung Damage in Influenza A Virus-infected Mice by Inhibiting Nitric Oxide Production. In Vivo 2018;32:473\u20138.","DOI":"10.21873\/invivo.11263"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_031_w2aab3b7b4b1b6b1ab1c11c31Aa","doi-asserted-by":"crossref","unstructured":"Schmidt ME, Varga SM. The CD8 T Cell Response to Respiratory Virus Infections. Front Immunol 2018;9:678.","DOI":"10.3389\/fimmu.2018.00678"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_032_w2aab3b7b4b1b6b1ab1c11c32Aa","doi-asserted-by":"crossref","unstructured":"Glezen WP. Clinical practice. Prevention and treatment of seasonal influenza. N Engl J Med 2008;359:2579\u201385.","DOI":"10.1056\/NEJMcp0807498"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_033_w2aab3b7b4b1b6b1ab1c11c33Aa","doi-asserted-by":"crossref","unstructured":"Paules C, Subbarao K. Influenza. The Lancet 2017;390:697\u2013708.","DOI":"10.1016\/S0140-6736(17)30129-0"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_034_w2aab3b7b4b1b6b1ab1c11c34Aa","doi-asserted-by":"crossref","unstructured":"van den Dool C, Hak E, Wallinga J, van Loon AM, Lammers JW, Bonten MJ. Symptoms of influenza virus infection in hospitalized patients. Infect Control Hosp Epidemiol 2008;29:314\u20139.","DOI":"10.1086\/529211"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_035_w2aab3b7b4b1b6b1ab1c11c35Aa","doi-asserted-by":"crossref","unstructured":"Pleschka S. Overview of influenza viruses. Curr Top Microbiol Immunol 2013;370:1\u201320.","DOI":"10.1007\/82_2012_272"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_036_w2aab3b7b4b1b6b1ab1c11c36Aa","doi-asserted-by":"crossref","unstructured":"Smith DB, Gaunt ER, Digard P, Templeton K, Simmonds P. Detection of influenza C virus but not influenza D virus in Scottish respiratory samples. J Clin Virol 2016;74:50\u20133.","DOI":"10.1016\/j.jcv.2015.11.036"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_037_w2aab3b7b4b1b6b1ab1c11c37Aa","doi-asserted-by":"crossref","unstructured":"Taubenberger JK, Kash JC. Influenza Virus Evolution, Host Adaptation and Pandemic Formation. Cell Host Microbe 2010;7:440\u201351.","DOI":"10.1016\/j.chom.2010.05.009"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_038_w2aab3b7b4b1b6b1ab1c11c38Aa","doi-asserted-by":"crossref","unstructured":"Sullivan SJ, Jacobson RM, Dowdle WR, Poland GA. 2009 H1N1 influenza. Mayo Clin Proc 2010;85:64\u201376.","DOI":"10.4065\/mcp.2009.0588"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_039_w2aab3b7b4b1b6b1ab1c11c39Aa","doi-asserted-by":"crossref","unstructured":"Peltola VT, Boyd KL, McAuley JL, Rehg JE, McCullers JA. Bacterial Sinusitis and Otitis Media following Influenza Virus Infection in Ferrets. Infect Immun 2006;74:2562\u20137.","DOI":"10.1128\/IAI.74.5.2562-2567.2006"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_040_w2aab3b7b4b1b6b1ab1c11c40Aa","doi-asserted-by":"crossref","unstructured":"Vardakas KZ, Theocharis G, Tansarli GS, Rafailidis P, Falagas ME. Impact of oseltamivir use on the reduction of complications in patients with influenza: a prospective study. Arch Virol 2016;161:2511\u20138.","DOI":"10.1007\/s00705-016-2941-5"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_041_w2aab3b7b4b1b6b1ab1c11c41Aa","doi-asserted-by":"crossref","unstructured":"Ukimura A, Satomi H, Ooi Y, Kanzaki Y. Myocarditis Associated with Influenza A H1N1pdm2009. Influenza Res Treat 2012;2012:351979.","DOI":"10.1155\/2012\/351979"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_042_w2aab3b7b4b1b6b1ab1c11c42Aa","doi-asserted-by":"crossref","unstructured":"Newland JG, Romero JR, Varman M, Drake C, Holst A, Safranek T, et al. Encephalitis Associated with Influenza B Virus Infection in 2 Children and a Review of the Literature. Clin Infect Dis 2003;36:e87\u2013e95.","DOI":"10.1086\/368184"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_043_w2aab3b7b4b1b6b1ab1c11c43Aa","doi-asserted-by":"crossref","unstructured":"Fadila MF, Wool KJ. Rhabdomyolysis Secondary to Influenza A Infection: A Case Report and Review of the Literature. N Am J Med Sci 2015;7:122\u20134.","DOI":"10.4103\/1947-2714.153926"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_044_w2aab3b7b4b1b6b1ab1c11c44Aa","doi-asserted-by":"crossref","unstructured":"Broadbent AJ, Subbarao K. Influenza Virus Vaccines: Lessons from the 2009 H1N1 pandemic. Curr Opin Virol 2011;1:254\u201362.","DOI":"10.1016\/j.coviro.2011.08.002"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_045_w2aab3b7b4b1b6b1ab1c11c45Aa","doi-asserted-by":"crossref","unstructured":"Sridhar S, Brokstad KA, Cox RJ. Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines. Vaccines (Basel) 2015;3:373\u201389.","DOI":"10.3390\/vaccines3020373"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_046_w2aab3b7b4b1b6b1ab1c11c46Aa","doi-asserted-by":"crossref","unstructured":"Tamura S, Ainai A, Suzuki T, Kurata T, Hasegawa H. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine? Jpn J Infect Dis 2016;69:165\u201379.","DOI":"10.7883\/yoken.JJID.2015.560"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_047_w2aab3b7b4b1b6b1ab1c11c47Aa","doi-asserted-by":"crossref","unstructured":"Christian LM, Porter K, Karlsson E, Schultz-Cherry S. Proinflammatory cytokine responses correspond with subjective side effects after influenza virus vaccination. Vaccine 2015;33:3360\u20136.","DOI":"10.1016\/j.vaccine.2015.05.008"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_048_w2aab3b7b4b1b6b1ab1c11c48Aa","doi-asserted-by":"crossref","unstructured":"Coleman BL, McNeil SA, Langley JM, Halperin SA, McGeer AJ. Differences in efficiency, satisfaction and adverse events between self-administered intradermal and nurse-administered intramuscular influenza vaccines in hospital workers. Vaccine 2015;33:6635\u201340.","DOI":"10.1016\/j.vaccine.2015.10.095"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_049_w2aab3b7b4b1b6b1ab1c11c49Aa","doi-asserted-by":"crossref","unstructured":"Urayoshi S, Matsumoto S, Miyatani H, Yoshida Y. A case of myositis of the deltoid muscle of the upper arm developing 1 week after influenza vaccination: case report. Clin Case Rep 2015;3:135\u20138.","DOI":"10.1002\/ccr3.177"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_050_w2aab3b7b4b1b6b1ab1c11c50Aa","doi-asserted-by":"crossref","unstructured":"Souayah N, Yacoub HA, Khan HM, Farhad K, Mehyar LS, Maybodi L, et al. Guillain-Barre syndrome after influenza vaccination in the United States, a report from the CDC\/FDA vaccine adverse event reporting system (1990\u20132009). J Clin Neuromuscul Dis 2012;14:66\u201371.","DOI":"10.1097\/CND.0b013e31824db14e"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_051_w2aab3b7b4b1b6b1ab1c11c51Aa","doi-asserted-by":"crossref","unstructured":"Park YS, Lee KJ, Kim SW, Kim KM, Suh BC. Clinical Features of Post-Vaccination Guillain-Barr\u00e9 Syndrome (GBS) in Korea. J Korean Med Sci 2017;32:1154\u20139.","DOI":"10.3346\/jkms.2017.32.7.1154"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_052_w2aab3b7b4b1b6b1ab1c11c52Aa","doi-asserted-by":"crossref","unstructured":"Sencer DJ, Millar JD. Reflections on the 1976 swine flu vaccination program. Emerg Infect Dis 2006;12:29\u201333.","DOI":"10.3201\/eid1201.051007"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_053_w2aab3b7b4b1b6b1ab1c11c53Aa","doi-asserted-by":"crossref","unstructured":"Kwong JC, Vasa PP, Campitelli MA, Hawken S, Wilson K, Rosella LC, et al. Risk of Guillain-Barre syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study. Lancet Infect Dis 2013;13:769\u201376.","DOI":"10.1016\/S1473-3099(13)70104-X"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_054_w2aab3b7b4b1b6b1ab1c11c54Aa","doi-asserted-by":"crossref","unstructured":"Park YS, Lee KJ, Kim SW, Kim KM, Suh BC. Clinical Features of Post-Vaccination Guillain-Barr\u00e9 Syndrome (GBS) in Korea. J Korean Med Sci 2017;32:1154\u20139.","DOI":"10.3346\/jkms.2017.32.7.1154"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_055_w2aab3b7b4b1b6b1ab1c11c55Aa","doi-asserted-by":"crossref","unstructured":"Polakowski LL, Sandhu SK, Martin DB, Ball R, MaCurdy TE, Franks RL, et al. Chart-Confirmed Guillain-Barr\u00e9 Syndrome After 2009 H1N1 Influenza Vaccination Among the Medicare Population, 2009\u20132010. Am J Epidemiol 2013;178:962\u201373.","DOI":"10.1093\/aje\/kwt051"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_056_w2aab3b7b4b1b6b1ab1c11c56Aa","doi-asserted-by":"crossref","unstructured":"Sivadon-Tardy V, Orlikowski D, Porcher R, Sharshar T, Durand M-C, Enouf V, et al. Guillain-Barr\u00e9 Syndrome and Influenza Virus Infection. Clin Infect Dis 2009;48:48\u201356.","DOI":"10.1086\/594124"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_057_w2aab3b7b4b1b6b1ab1c11c57Aa","doi-asserted-by":"crossref","unstructured":"Sellers SA, Hagan RS, Hayden FG, Fischer WA 2nd. The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection. Influenza Other Respir Viruses 2017;11:372\u201393.","DOI":"10.1111\/irv.12470"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_058_w2aab3b7b4b1b6b1ab1c11c58Aa","doi-asserted-by":"crossref","unstructured":"Ghaderi S, Gunnes N, Bakken IJ, Magnus P, Trogstad L, Haberg SE. Risk of Guillain-Barre syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study. Eur J Epidemiol 2016;31:67\u201372.","DOI":"10.1007\/s10654-015-0047-0"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_059_w2aab3b7b4b1b6b1ab1c11c59Aa","doi-asserted-by":"crossref","unstructured":"Wang DJ, Boltz DA, McElhaney J, McCullers JA, Webby RJ, Webster RG. No evidence of a link between influenza vaccines and Guillain-Barre syndrome-associated antiganglioside antibodies. Influenza Other Respir Viruses 2012;6:159\u201366.","DOI":"10.1111\/j.1750-2659.2011.00294.x"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_060_w2aab3b7b4b1b6b1ab1c11c60Aa","doi-asserted-by":"crossref","unstructured":"Souayah N, Yacoub HA, Khan HMR, Michas-Martin PA, Menkes DL, Maybodi L, et al. Guillain-Barr\u00e9 Syndrome after H1N1 Vaccination in the United States: A Report Using the CDC\/FDA Vaccine Adverse Event Reporting System (2009). Neuroepidemiology 2012;38:227\u201332.","DOI":"10.1159\/000336113"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_061_w2aab3b7b4b1b6b1ab1c11c61Aa","doi-asserted-by":"crossref","unstructured":"Mathew T, Srinivas M, Nadig R, Arumugam R, Sarma GRK. Seasonal and monthly trends in the occurrence of Guillain-Barre syndrome over a 5-year period: A tertiary care hospital-based study from South India. Ann Indian Acad Neurol 2014;17:239\u201341.","DOI":"10.4103\/0972-2327.132662"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_062_w2aab3b7b4b1b6b1ab1c11c62Aa","doi-asserted-by":"crossref","unstructured":"McCarthy EA, Pollock WE, Tapper L, Sommerville M, McDonald S. Increasing uptake of influenza vaccine by pregnant women post H1N1 pandemic: a longitudinal study in Melbourne, Australia, 2010 to 2014. BMC Pregnancy Childbirth 2015;15:53.","DOI":"10.1186\/s12884-015-0486-3"},{"key":"2023042508114206751_j_jtim-2019-0028_ref_063_w2aab3b7b4b1b6b1ab1c11c63Aa","doi-asserted-by":"crossref","unstructured":"Nakagawa N, Higashi N, Nakagawa T. Cocirculation of Antigenic Variants and the Vaccine-Type Virus during the 2004\u20132005 Influenza B Virus Epidemics in Japan. J Clin Microbiol 2009;47:352\u20137.","DOI":"10.1128\/JCM.01357-08"}],"container-title":["Journal of Translational Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/content.sciendo.com\/view\/journals\/jtim\/7\/4\/article-p137.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.2478\/jtim-2019-0028\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.2478\/jtim-2019-0028\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T08:26:57Z","timestamp":1682411217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.2478\/jtim-2019-0028\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,1]]},"references-count":63,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,12,31]]},"published-print":{"date-parts":[[2019,12,1]]}},"alternative-id":["10.2478\/jtim-2019-0028"],"URL":"https:\/\/doi.org\/10.2478\/jtim-2019-0028","relation":{},"ISSN":["2224-4018"],"issn-type":[{"value":"2224-4018","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,1]]}}}